Literature DB >> 30831381

Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina.

Pranav Dinesh Mathur1, Jun Yang2.   

Abstract

Usher syndrome (USH) is the leading cause of inherited combined vision and hearing loss. However, mutations in most USH causative genes lead to other diseases, such as hearing loss only or vision loss only. The molecular mechanisms underlying the variable disease manifestations associated with USH gene mutations are unclear. This review focuses on an USH type 2 (USH2) gene encoding whirlin (WHRN; previously known as DFNB31), mutations in which have been found to cause either USH2 subtype USH2D or autosomal recessive non-syndromic deafness type 31 (DFNB31). This review summarizes the current knowledge about different whirlin isoforms encoded by WHRN orthologs in animal models, the interactions of different whirlin isoforms with their partners, and the function of whirlin isoforms in different cellular and subcellular locations. The recent findings regarding the function of whirlin isoforms suggest that disruption of different isoforms may be one of the mechanisms underlying the variable disease manifestations caused by USH gene mutations. This review also presents recent findings about the vestibular defects in Whrn mutant mouse models, which suggests that previous assumptions about the normal vestibular function of USH2 patients need to be re-evaluated. Finally, this review describes recent progress in developing therapeutics for diseases caused by WHRN mutations.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ankle link; Hair cell; Hearing loss; Photoreceptor; Retinitis pigmentosa; Stereocilia; Usher syndrome

Mesh:

Substances:

Year:  2019        PMID: 30831381      PMCID: PMC6474673          DOI: 10.1016/j.heares.2019.02.007

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  56 in total

1.  Non-USH2A mutations in USH2 patients.

Authors:  Thomas Besnard; Christel Vaché; David Baux; Lise Larrieu; Caroline Abadie; Catherine Blanchet; Sylvie Odent; Patricia Blanchet; Patrick Calvas; Christian Hamel; Hélène Dollfus; Geneviève Lina-Granade; James Lespinasse; Albert David; Bertrand Isidor; Gilles Morin; Sue Malcolm; Sylvie Tuffery-Giraud; Mireille Claustres; Anne-Françoise Roux
Journal:  Hum Mutat       Date:  2012-01-06       Impact factor: 4.878

2.  Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome.

Authors:  X Z Liu; C Hope; J Walsh; V Newton; X M Ke; C Y Liang; L R Xu; J M Zhou; D Trump; K P Steel; S Bundey; S D Brown
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

3.  Myosin-XVa is required for tip localization of whirlin and differential elongation of hair-cell stereocilia.

Authors:  Inna A Belyantseva; Erich T Boger; Sadaf Naz; Gregory I Frolenkov; James R Sellers; Zubair M Ahmed; Andrew J Griffith; Thomas B Friedman
Journal:  Nat Cell Biol       Date:  2005-01-16       Impact factor: 28.824

4.  Usher syndrome: definition and estimate of prevalence from two high-risk populations.

Authors:  J A Boughman; M Vernon; K A Shaver
Journal:  J Chronic Dis       Date:  1983

5.  Whirlin replacement restores the formation of the USH2 protein complex in whirlin knockout photoreceptors.

Authors:  Junhuang Zou; Ling Luo; Zuolian Shen; Vince A Chiodo; Balamurali K Ambati; William W Hauswirth; Jun Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-12       Impact factor: 4.799

6.  Regulation of synaptic development and function by the Drosophila PDZ protein Dyschronic.

Authors:  James E C Jepson; Mohammed Shahidullah; Die Liu; Sylvain J le Marchand; Sha Liu; Mark N Wu; Irwin B Levitan; Matthew B Dalva; Kyunghee Koh
Journal:  Development       Date:  2014-10-30       Impact factor: 6.868

7.  CIP98, a novel PDZ domain protein, is expressed in the central nervous system and interacts with calmodulin-dependent serine kinase.

Authors:  Chan Choo Yap; Fengyi Liang; Yasuhiro Yamazaki; Yuko Muto; Haruo Kishida; Tsuyako Hayashida; Tsutomu Hashikawa; Ryoji Yano
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

8.  Gene Therapy Restores Hair Cell Stereocilia Morphology in Inner Ears of Deaf Whirler Mice.

Authors:  Wade W Chien; Kevin Isgrig; Soumen Roy; Inna A Belyantseva; Meghan C Drummond; Lindsey A May; Tracy S Fitzgerald; Thomas B Friedman; Lisa L Cunningham
Journal:  Mol Ther       Date:  2015-08-26       Impact factor: 11.454

9.  Molecular epidemiology of Usher syndrome in Italy.

Authors:  Diego Vozzi; Anu Aaspõllu; Emmanouil Athanasakis; Anna Berto; Antonella Fabretto; Danilo Licastro; Maigi Külm; Francesco Testa; Patrizia Trevisi; Marju Vahter; Carmela Ziviello; Alessandro Martini; Francesca Simonelli; Sandro Banfi; Paolo Gasparini
Journal:  Mol Vis       Date:  2011-06-22       Impact factor: 2.367

10.  Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.

Authors:  Jacqueline K White; Anna-Karin Gerdin; Natasha A Karp; Ed Ryder; Marija Buljan; James N Bussell; Jennifer Salisbury; Simon Clare; Neil J Ingham; Christine Podrini; Richard Houghton; Jeanne Estabel; Joanna R Bottomley; David G Melvin; David Sunter; Niels C Adams; David Tannahill; Darren W Logan; Daniel G Macarthur; Jonathan Flint; Vinit B Mahajan; Stephen H Tsang; Ian Smyth; Fiona M Watt; William C Skarnes; Gordon Dougan; David J Adams; Ramiro Ramirez-Solis; Allan Bradley; Karen P Steel
Journal:  Cell       Date:  2013-07-18       Impact factor: 41.582

View more
  13 in total

1.  Identification of a novel homozygous ARSG mutation as the second cause of Usher syndrome type 4.

Authors:  Víctor Abad-Morales; Rafael Navarro; Anniken Burés-Jelstrup; Esther Pomares
Journal:  Am J Ophthalmol Case Rep       Date:  2020-05-08

Review 2.  Gene Therapy to the Retina and the Cochlea.

Authors:  Ryan Crane; Shannon M Conley; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Front Neurosci       Date:  2021-03-17       Impact factor: 4.677

3.  Phylogenetic analysis of Harmonin homology domains.

Authors:  Baptiste Colcombet-Cazenave; Karen Druart; Crystel Bonnet; Christine Petit; Olivier Spérandio; Julien Guglielmini; Nicolas Wolff
Journal:  BMC Bioinformatics       Date:  2021-04-14       Impact factor: 3.169

Review 4.  Usher Syndrome.

Authors:  Alessandro Castiglione; Claes Möller
Journal:  Audiol Res       Date:  2022-01-11

Review 5.  Vestibular Deficits in Deafness: Clinical Presentation, Animal Modeling, and Treatment Solutions.

Authors:  Audrey Maudoux; Sandrine Vitry; Aziz El-Amraoui
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.003

Review 6.  Usher Syndrome: Genetics of a Human Ciliopathy.

Authors:  Carla Fuster-García; Belén García-Bohórquez; Ana Rodríguez-Muñoz; Elena Aller; Teresa Jaijo; José M Millán; Gema García-García
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

7.  A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome.

Authors:  Lucy S French; Carla B Mellough; Fred K Chen; Livia S Carvalho
Journal:  Front Cell Neurosci       Date:  2020-07-09       Impact factor: 5.505

8.  Aberrant Splicing Events Associated to CDH23 Noncanonical Splice Site Mutations in a Proband with Atypical Usher Syndrome 1.

Authors:  Rebeca Valero; Marta de Castro-Miró; Sofía Jiménez-Ochoa; Juan José Rodríguez-Ezcurra; Gemma Marfany; Roser Gonzàlez-Duarte
Journal:  Genes (Basel)       Date:  2019-09-21       Impact factor: 4.096

Review 9.  Usher Syndrome: Genetics and Molecular Links of Hearing Loss and Directions for Therapy.

Authors:  Meg Whatley; Abbie Francis; Zi Ying Ng; Xin Ee Khoh; Marcus D Atlas; Rodney J Dilley; Elaine Y M Wong
Journal:  Front Genet       Date:  2020-10-22       Impact factor: 4.599

Review 10.  Understanding the Pathophysiology of Congenital Vestibular Disorders: Current Challenges and Future Directions.

Authors:  Kenna D Peusner; Nina M Bell; June C Hirsch; Mathieu Beraneck; Anastas Popratiloff
Journal:  Front Neurol       Date:  2021-09-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.